Thrombosis and Haemostasis publishes original articles with a broad scope in basic research and clinical studies in vascular biology and medicine, covering blood coagulation, fibrinolysis and cellular haemostasis; platelets and blood cells; wound healing and inflammation/infection; endothelium and vascular development; cardiovascular biology and cell signalling; cellular proteolysis and oncology; new technologies, diagnostic tools and drugs; animal models.
Scientists have identified how and why some COVID-19 patients can develop life-threatening clots, which could lead to targeted therapies that prevent this from happening.
Jun 15, 2021
0
9
An international team of researchers led by the Universities of Liverpool and Keele, working with Public Health England, has found that the common anticoagulant drug heparin inhibits the SARS-Cov2 virus spike protein, by ...
Jan 28, 2021
2
727
Why so many COVID-19 patients get blood clots (thrombosis) remains uncertain. But scientists at Uppsala University and the University Hospital have now identified a mechanism they believe to be implicated. A particular protein ...
Sep 2, 2020
0
17
Impaired blood clotting after surgery or major injury can lead to severe bleeding or hemorrhage in patients if they are not rapidly treated with blood transfusions.
Jun 26, 2020
0
3
(Medical Xpress)—Opportunistic detection of asymptomatic atrial fibrillation (AF) and treating it with anticoagulants can greatly reduce the risk of stroke and premature death, a new landmark study reveals.
Jun 20, 2014
0
0
(Medical Xpress)—University of Sydney researchers have examined a unique way to identify the thousands of people at risk of stroke every year, using an ECG test delivered over an IPhone by pharmacists.
Apr 2, 2014
0
0
A new article in the September 2013 issue of Thrombosis and Haemostasis strives to shed light on the optimal antithrombotic strategy in patients suffering from atrial fibrillation who undergo coronary stent implantation. ...
Sep 2, 2013
0
0
Wine and beer in moderate doses may protect against venous thrombosis, but consumption of more than 14 standard drinks per week increases the risk of the same condition, in particular pulmonary embolism, in both men and women, ...
Jul 4, 2013
0
0
The Cardiovascular Research Laboratory of the Bellvitge Biomedical Research Institute (IDIBELL) led by the cardiologist of the Bellvitge University Hospital José Luis Ferreiro has conducted a study on the effect of antiplatelet ...
Jun 6, 2013
0
0
Within the past decade, the variability in pharmacodynamic response and moderate antiplatelet efficacy of clopidogrel has raised major concerns, in particular because it is associated with an increased risk for ischemic events ...
May 6, 2013
0
0
